Moreover, Martens and colleagues reported that PSAT1 is overexpressed in some breast cancer samples and that this overexpression is associated with unfavorable clinical outcome in patients treated with the antiestrogen tamoxifen [14]. The gene discussed is PSAT1; the disease is breast cancer.